Moderna, Inc. vs Invesco Solar ETF — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Invesco Solar ETF trades at $53.77. The key difference: Moderna, Inc. is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals.
| MRNA | TAN | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | Sector/Thematic |
52-Week High | $81.80 | $73.95 |
52-Week Low | $22.36 | $36.07 |
Enterprise Value | $19.70B | — |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →